Celldex Therapeutics annual gross profit
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Celldex Therapeutics Gross Profit Growth & History (CLDX)
Celldex Therapeutics's gross profit was $1.3M for fiscal 2025.
View full Celldex Therapeutics company overviewCelldex Therapeutics annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.3M | −$5.5M | −80.28% |
| 2024 | 2024-12-31 | $6.8M | $237,000 | +3.60% |
| 2023 | 2023-12-31 | $6.6M | $4.3M | +191.67% |
| 2022 | 2022-12-31 | $2.3M | −$2.3M | −50.41% |
| 2021 | 2021-12-31 | $4.6M | −$2.7M | −36.95% |
| 2020 | 2020-12-31 | $7.2M | $3.7M | +107.83% |
| 2019 | 2019-12-31 | $3.5M | −$5.4M | −60.70% |
| 2018 | 2018-12-31 | $8.8M | −$3.2M | −26.61% |
| 2017 | 2017-12-31 | $12.0M | $6.9M | +132.22% |
| 2016 | 2016-12-31 | $5.2M | — | — |
Celldex Therapeutics gross profit trends
Over the last five fiscal years, Celldex Therapeutics's gross profit decreased from $7.2M to $1.3M, a change of −$5.9M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Celldex Therapeutics source filings ↗